Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Crohn's Disease, Active”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07499232
What this trial is testing

Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 530
Testing effectiveness (Phase 2)Study completedNCT03546868
What this trial is testing

Diagnostic Validity of [18F]FSPG PET for the Assessment of Disease Activity in Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel DiseasesUlcerative ColitisCrohn Disease
Asan Foundation 20
Not applicableStudy completedNCT07211789
What this trial is testing

Real World Evidence Study With Restrictive Diet and Otral Nutritional Supplementation on Pediatric Patients With Active Chron Disease

Who this might be right for
Crohn Disease
Outcomes'10 58
Not applicableStudy completedNCT04535882
What this trial is testing

Effectiveness of Serum Leucine-rich Alpha-2 Glycoprotein Levels on IBD

Who this might be right for
LRG Levels
Showa Inan General Hospital 673
Large-scale testing (Phase 3)Study completedNCT00152425
What this trial is testing

Study to Test the Effect of CDP870 in the Treatment of Crohn's Disease Over 26 Weeks, Comparing CDP870 to a Dummy Drug (Placebo), Following 3 Doses of Active Drug (CDP870).

Who this might be right for
Crohn's Disease
UCB Pharma 392
Testing effectiveness (Phase 2)Study completedNCT02031276
What this trial is testing

Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease.

Who this might be right for
Crohn Disease
AbbVie 121
Not applicableStudy completedNCT03351647
What this trial is testing

Predictive Factors of Clinical Response to Ustekinumab in Active Crohn's Disease

Who this might be right for
Crohn Disease
Hospices Civils de Lyon 18
Large-scale testing (Phase 3)Active Not RecruitingNCT05197049
What this trial is testing

Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 350
Early research (Phase 1)Looking for participantsNCT06902987
What this trial is testing

Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease

Who this might be right for
Crohn's DiseasesActive Anal FistulaUpadacitinib
Sixth Affiliated Hospital, Sun Yat-sen University 27
Large-scale testing (Phase 3)Ended earlyNCT02596893
What this trial is testing

Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 701
Large-scale testing (Phase 3)Active Not RecruitingNCT04524611
What this trial is testing

Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

Who this might be right for
Crohn's Disease (CD)
AbbVie 527
Large-scale testing (Phase 3)Ended earlyNCT03440372
What this trial is testing

Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Celgene 625
Large-scale testing (Phase 3)Looking for participantsNCT06819878
What this trial is testing

Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohns Disease
Hoffmann-La Roche 600
Testing effectiveness (Phase 2)Study completedNCT01751152
What this trial is testing

A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Who this might be right for
InflammationCrohn's Disease
Novo Nordisk A/S 53
Post-approval studies (Phase 4)Looking for participantsNCT06257706
What this trial is testing

VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease

Who this might be right for
Moderately to Severely Active Crohn's DiseaseCrohn DiseaseDisease Crohn
Alimentiv Inc. 304
Testing effectiveness (Phase 2)Ended earlyNCT00792740
What this trial is testing

Effect of ITF2357 on Mucosal Healing in Patients With Moderate-to-severe Active Crohn's Disease

Who this might be right for
Crohn's Disease
Italfarmaco 51
Large-scale testing (Phase 3)WithdrawnNCT04643483
What this trial is testing

Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
UCB Biopharma SRL
Not applicableUnknownNCT02445690
What this trial is testing

Thrombin Generation in Crohn's Disease

Who this might be right for
Crohn DiseaseBlood ClotThrombosis
University of Sao Paulo General Hospital 150
Large-scale testing (Phase 3)Study completedNCT00206674
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 286
Testing effectiveness (Phase 2)Ended earlyNCT00317369
What this trial is testing

A Dose-finding Study of OPC-6535 in Patients With Active Crohn's Disease

Who this might be right for
Crohn Disease
Otsuka Pharmaceutical Co., Ltd. 29
Next Page